Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Biology researchers and drug developers need faster, cheaper, more accurate ways to synthesize long sequences of DNA. Cambridge, UK-based Evonetix has designed silicon chips that use thermal control and a phenomenon called dielectrophoresis to construct and transport oligonucleotide sequences — assembling short strands of DNA into long strands with up to thousands of base pairs, with built-in error correction. The ability to rapidly prototype genes and pathways using synthesized DNA could unlock opportunities in healthcare, energy, agriculture, materials, and data storage.
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules